Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:484210rdf:typepubmed:Citationlld:pubmed
pubmed-article:484210lifeskim:mentionsumls-concept:C0025914lld:lifeskim
pubmed-article:484210lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:484210lifeskim:mentionsumls-concept:C0596208lld:lifeskim
pubmed-article:484210lifeskim:mentionsumls-concept:C0521457lld:lifeskim
pubmed-article:484210lifeskim:mentionsumls-concept:C0205307lld:lifeskim
pubmed-article:484210lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:484210pubmed:issue3lld:pubmed
pubmed-article:484210pubmed:dateCreated1979-11-28lld:pubmed
pubmed-article:484210pubmed:abstractTextAn ultrastructural study was performed on normal and Benzo(a)-pyrene(B(a)P)-transformed fetal mouse brain cells. Early subcultures of a strain initiated from whole brain presented three cell types in vitro: astroglial, poorly differentiated glial, and spongioblastic types. After B(a)P-treatment, there was an exclusive transformation and the growth of neuroglia sometimes without gliofibrillary maturation, but with the presence of glial fibrillary acidic protein (GFAP) in the cytoplasm. Early subcultures of another strain initiated from cortex only presented poorly differentiated neuroglial cells. After transformation, cell maturation as evidenced by gliofibrillogenesis and GFAP production by these cells was observed. In both cases, the potentiality of glial differentiation after in vitro malignant transformation by a chemical carcinogen seemed preserved.lld:pubmed
pubmed-article:484210pubmed:languageenglld:pubmed
pubmed-article:484210pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:484210pubmed:citationSubsetIMlld:pubmed
pubmed-article:484210pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:484210pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:484210pubmed:statusMEDLINElld:pubmed
pubmed-article:484210pubmed:monthAuglld:pubmed
pubmed-article:484210pubmed:issn0001-6322lld:pubmed
pubmed-article:484210pubmed:authorpubmed-author:TogaMMlld:pubmed
pubmed-article:484210pubmed:authorpubmed-author:TripierM FMFlld:pubmed
pubmed-article:484210pubmed:authorpubmed-author:MarkovitsPPlld:pubmed
pubmed-article:484210pubmed:authorpubmed-author:PapadopouloDDlld:pubmed
pubmed-article:484210pubmed:issnTypePrintlld:pubmed
pubmed-article:484210pubmed:volume47lld:pubmed
pubmed-article:484210pubmed:ownerNLMlld:pubmed
pubmed-article:484210pubmed:authorsCompleteYlld:pubmed
pubmed-article:484210pubmed:pagination205-11lld:pubmed
pubmed-article:484210pubmed:dateRevised2007-11-9lld:pubmed
pubmed-article:484210pubmed:meshHeadingpubmed-meshheading:484210-A...lld:pubmed
pubmed-article:484210pubmed:meshHeadingpubmed-meshheading:484210-M...lld:pubmed
pubmed-article:484210pubmed:meshHeadingpubmed-meshheading:484210-B...lld:pubmed
pubmed-article:484210pubmed:meshHeadingpubmed-meshheading:484210-B...lld:pubmed
pubmed-article:484210pubmed:meshHeadingpubmed-meshheading:484210-M...lld:pubmed
pubmed-article:484210pubmed:meshHeadingpubmed-meshheading:484210-B...lld:pubmed
pubmed-article:484210pubmed:meshHeadingpubmed-meshheading:484210-N...lld:pubmed
pubmed-article:484210pubmed:meshHeadingpubmed-meshheading:484210-C...lld:pubmed
pubmed-article:484210pubmed:meshHeadingpubmed-meshheading:484210-A...lld:pubmed
pubmed-article:484210pubmed:meshHeadingpubmed-meshheading:484210-N...lld:pubmed
pubmed-article:484210pubmed:year1979lld:pubmed
pubmed-article:484210pubmed:articleTitleNormal and benzo(a)pyrene-transformed fetal mouse brain cells. II. Ultrastructural study.lld:pubmed
pubmed-article:484210pubmed:publicationTypeJournal Articlelld:pubmed